Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Perkin Elmer Develops Billerica Manufacturing Facility
PerkinElmer Life Sciences, based in Boston, has a new 3,800-sf manufacturing building under construction in Billerica. The renovated space will accommodate 10-12 employees. The plant will produce Yttrium 90 for use in radiotherapeutic cancer treatment. It is anticipated that the facility will be operational in early 2002.
Abbott Labs Proposes Redwood City Expansion
Abbott Labs has proposed a 1,000,000-sf expanison in Redwood City, providing manufacturing and R&D facilities for the Chicago-based bioscience company's cardiac products. Maximizing the company's proximity to the world-class cardiac clinics at Sequoia Hospital and Stanford Hospital, Abbot purchased the Redwood City-based Perclose biotech in 1999. Abbott plans to spend up to $350 million on the new complex. Ground may be broken on the three-phase project by the end of 2002.
UT-San Antonio Breaks Ground on Durango Addition
The University of Texas at San Antonio (UTSA) broke ground in January 2002 on its 33,000-sf Durango Building addition. Slated for completion in March of 2003, the $7 million additon will house UTSA's Institute for Economic Development.
Toyota Builds Tijuana Manufacturing Plant
Toyota is planning to build a plant in Tijuana to manufacture its Tacoma pickup truck beds. Located on 700 acres in eastern Tijuana, the plant will produce 160,000 truck beds annually. Construction is slated to begin in spring of 2002 with production to begin at the plant in 2004.
Novo Nordisk Insulin Plant On Hold
Plans to construct a second insulin manufacturing plant in Clayton have been put on hold by Novo Nordisk Pharmaceuticals' Danish parent company due to research delays. The plant would manufacture insulin in the form of an inhalant, the clinical trials of which have been delayed. Novo Nordisk's existing insulin manufacturing plant occupies 50 of 260 acres owned by the pharmaceutical firm in Clayton; the new plant would be constructed adjacent to it.